SCHEMBL3402273

SCHEMBL3402273

CCOc1ccccc1-c1nc(C)c(C(=O)N(C)CCN(CC)CC)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 6/20 0.54
TRPM8 Q7Z2W7 2/20 0.42
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.41
ALDH1A1 P00352 4/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399658 0.85 HTR2C (0.58) HTR2CTRPM8LMNAALDH1A1NPC1
SCHEMBL3402422 0.84 HTR2C (0.55) HTR2CTRPM8LMNAALDH1A1NPC1
SCHEMBL3401263 0.84 HTR2C (0.57) HTR2CTRPM8ALDH1A1NPC1RAB9A
SCHEMBL3405420 0.83 HTR2C (0.78) HTR2CTRPM8ALDH1A1NPC1RAB9A
SCHEMBL3401487 0.82 HTR2C (0.55) HTR2CTRPM8ALDH1A1NPC1RAB9A
SCHEMBL3402536 0.82 HTR2C (0.52) HTR2CTRPM8LMNAALDH1A1NPC1
SCHEMBL3398602 0.82 HTR2C (0.57) HTR2CTRPM8THRBALDH1A1NPC1
SCHEMBL3403609 0.81 HTR2C (0.62) HTR2CTRPM8LMNAALDH1A1NPC1
SCHEMBL3401033 0.81 TARBP2 (0.49) HTR2CTRPM8LMNAALDH1A1NPC1
SCHEMBL3405494 0.80 HTR2C (0.55) HTR2CTRPM8ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues LIGAND PHARMACEUTICALS, INC. (US) 2010-11-25 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues HRH3, HRH4, HRH2 HTR2C 416/4885TRPM8 455/4885LMNA 4548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.